Related Experiment Video
Updated: Jul 24, 2025
07:34
Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
Published on: June 2, 2019
9.8K
Transmembrane Stem Factor Nanodiscs Enhanced Revascularization in a Hind Limb Ischemia Model in Diabetic,
Eri Takematsu1, Miles Massidda1, Gretchen Howe2
1The University of Texas at Austin.
Research Square
|July 3, 2023
Summary
Transmembrane stem cell factor (SCF) delivered in nanodiscs effectively promotes blood vessel growth in a rabbit model of peripheral ischemia. This novel therapy shows promise for treating vascular disease without causing adverse mast cell activation.
Area of Science:
- Regenerative Medicine
- Vascular Biology
- Nanotechnology in Therapeutics
Background:
- Revascularization therapies aim to restore blood flow to ischemic tissues, crucial for treating conditions like peripheral artery disease.
- Previous stem cell factor (SCF) therapies faced limitations due to toxic side effects, including mast cell activation.
- A novel transmembrane SCF (tmSCF) delivered in lipid nanodiscs has shown promise in preclinical models without inducing mast cell activation.
Conclusions:
- tmSCF nanodiscs demonstrate significant therapeutic potential for promoting revascularization in peripheral ischemia.
- This novel nanodisc-based therapy offers a promising, safe alternative to previous SCF-based treatments for vascular disorders.
- The findings support the advancement of tmSCF nanodiscs towards clinical application for peripheral ischemia treatment.
